株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ヒト微生物叢 (ヒトマイクロバイオーム) の世界市場 2025年までの予測:適応症、用途、製品、製品研究、技術研究別

Human Microbiome Market by Indication (Obesity, Cancer), Application (Therapeutic, Diagnostic), Product (Prebiotics, Food, Drugs), Product Research (Instruments, Consumables), Technology Research (HTS, Omics Technologies) - Global Forecast to 2025

発行 MarketsandMarkets 商品コード 312652
出版日 ページ情報 英文 150 Pages
即納可能
価格
本日の銀行送金レート: 1USD=111.44円で換算しております。
Back to Top
ヒト微生物叢 (ヒトマイクロバイオーム) の世界市場 2025年までの予測:適応症、用途、製品、製品研究、技術研究別 Human Microbiome Market by Indication (Obesity, Cancer), Application (Therapeutic, Diagnostic), Product (Prebiotics, Food, Drugs), Product Research (Instruments, Consumables), Technology Research (HTS, Omics Technologies) - Global Forecast to 2025
出版日: 2017年03月06日 ページ情報: 英文 150 Pages
概要

世界のヒト微生物叢 (ヒトマイクロバイオーム) 市場は、2022年に5億650億米ドルに達し、その後2025年までCAGR21.1%で成長を続け、2025年には8億9,910万米ドルに達する見込みです。同市場は主に用途、疾患、製品の3分野に分かれています。様々な製品とその使用方法が市場全体の成長に影響しています。生活習慣病の増加が市場成長を促し、用途部門もまた大きな市場成長因子と考えられています。

レポートでは、世界のヒト微生物叢 (ヒトマイクロバイオーム) 市場について調査し、市場の動向と発展動向とともに、適応別、用途別、製品別、地域別動向、および参入する主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 プレミアムインサイト

第5章 市場概要

  • イントロダクション
  • 市場動向
    • 促進因子
    • 阻害因子
    • 機会
    • 課題
    • 喫緊の問題
  • 特許
  • 資金調達

第6章 製品別市場

  • イントロダクション
  • プロバイオティクス
  • 食品
  • プレバイオティクス
  • 医療用食品
  • 診断機器
  • 薬剤
  • その他のプロバイオティクスサプリメント

第7章 用途別市場

  • イントロダクション
  • 治療
  • 診断

第8章 疾患別市場

  • イントロダクション
  • 急性の下痢
  • 肥満
  • 糖尿病
  • 自己免疫疾患
  • 精神疾患
  • その他

第9章 製品別市場

  • イントロダクション
  • 装置
  • 消耗品

第10章 技術別市場

  • イントロダクション
  • 細胞培養技術
  • ハイスループット技術
  • オミクス技術
  • コンピュータツール

第11章 地域別分析

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • その他

第12章 競合環境

  • 概要
  • 競合動向

第13章 企業プロファイル

第14章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: BT 2711

The global human microbiome market is estimated to reach USD 899.1 million by 2025, growing at a CAGR of 21.1% during the forecast period (2022-2025).

Factors such as increased focus on human microbiome therapy, growing demand for human microbiomes as new validated targets for drug development, and the need for early disease detection and diagnosis are expected to drive the growth of the human microbiome market.

By product, the global human microbiome market is classified into probiotics, prebiotics, foods, medical foods, supplements, diagnostic devices, and drugs. The expectation that microbiome products, which will aid in the early-stage treatment of chronic diseases and various disorders, will be available in the market in the future is a key driver for the growth of this market. Other factors such as the rise in aging population, incidence of chronic health problems, and the need to cut healthcare costs will increase the adoption of microbiome-derived products. However, patent applications of microbiome-derived products will require clinical evidence and regulatory approvals; therefore, the promise of significant investment in this segment is uncertain.

Europe currently forms the largest human microbiome market in terms of demand for prebiotics and probiotics. The North American region is expected to register the highest growth rate due to its immense growth opportunities. Scientific evidence of health benefits of certain ingredients such as probiotics, prebiotics, etc. and the search for new opportunities to add value to the existing products are also expected to propel the global market growth. The demand for prebiotics and probiotics is increasing across various regions owing to the awareness among consumers regarding the favorable benefits of the microbiome community also referred as "friendly" bacteria. Most of the consumers prefer these products for maintaining good health and to use enhanced efficiency of ingredients, which offer products with bio-therapeutic properties. With the advancement in technology, the usage of probiotics is likely to extend beyond the current arena of gut, dental, and immune health to several other areas of human health.

Moreover, the rising incidence of cardiac diseases and other diseases such as diabetes and obesity are also expected to contribute to the growth of the human microbiome market. Increasing side effects and diminishing of human gut flora, due to excessive use of antibiotics, is likely to drive the growth of the human microbiome market. The application market is also expected to be a prominent segment owing to the use of microbiome as diagnostics and therapeutics.

The competitive landscape covers the current product pipelines of the industry players in various stages of the clinical trial development. The company profiles comprise the basic views on the key players in the human microbiome market and the product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future.

The above mentioned market research data, market potential, future market size, and forecast of future trends will help the key players and new entrants to make the necessary decisions regarding market penetration, product development/innovation, market development, market diversification, and competitive assessment, product offerings, geographic focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful in the market.

Research Coverage:

The report provides a picture on human microbiome across different industry verticals and regions. It aims at estimating the market size and future growth potential of this market across different segments such as product, disease, application, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market by providing them the closest approximations of the revenue numbers for the overall human microbiome market and the subsegments. This report will help stakeholders to better understand the competitor landscape and gain more insights to better position their businesses and make suitable go-to-market strategies. The report also helps the stakeholders to understand the pulse of the market and provides them information on key market drivers, restraints, challenges, and opportunities.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for increasing their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the human microbiome market. The report analyzes the human microbiome market by product, application, disease, and region
  • Product Development/Innovation: Detailed insights on the upcoming trends, research and development activities, and new product launches in the human microbiome market
  • Market Development: Comprehensive information about the lucrative emerging markets, by product and region
  • Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the human microbiome market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, products, and manufacturing capabilities of leading players in the human microbiome market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH APPROACH
  • 2.2. MARKET SIZE ESTIMATION
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
    • 2.3.1. KEY DATA FROM SECONDARY SOURCES
    • 2.3.2. KEY DATA FROM PRIMARY SOURCES
    • 2.3.3. KEY INDUSTRY INSIGHTS
    • 2.3.4. ASSUMPTIONS

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. HUMAN MICROBIOME : MARKET OVERVIEW
  • 4.2. GLOBAL HUMAN MICROBIOME MARKET, BY PRODUCT (2022)
  • 4.3. HUMAN MICROBIOME MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • 4.4. HUMAN MICROBIOME MARKET: GEOGRAPHIC MIX
  • 4.5. HUMAN MICROBIOME MARKET: DEVELOPING VS. DEVELOPED REGIONS
  • 4.6. HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY TECHNOLOGY

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Increased focus on human microbiome therapy
      • 5.2.1.2. Human microbiome as new validated target for drug development
      • 5.2.1.3. Human microbiome for early disease detection and diagnosis
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Lack of expertise and detailed research
      • 5.2.2.2. Barriers in proving the causal link between dysbiosis and disease
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Investigational New Drug (IND) requirements for fecal microbiota
      • 5.2.3.2. Increasing collaborations create growth opportunities
    • 5.2.4. CHALLENGE
      • 5.2.4.1. Government regulations
    • 5.2.5. BURNING ISSUES
      • 5.2.5.1. Abundant opportunities in the human microbiome field and tremendous research investments
      • 5.2.5.2. Development of human microbiome therapeutic products
  • 5.3. HUMAN MICROBIOME MARKET: PATENTS
  • 5.4. HUMAN MICROBIOME MARKET: FUNDING

6. HUMAN MICROBIOME MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. PROBIOTICS
  • 6.3. FOODS
  • 6.4. PREBIOTICS
  • 6.5. MEDICAL FOODS
  • 6.6. DIAGNOSTIC DEVICES
  • 6.7. DRUGS
  • 6.8. OTHER PROBIOTIC SUPPLEMENTS

7. HUMAN MICROBIOME MARKET, BY APPLICATION

  • 7.1. INTRODUCTION
  • 7.2. THERAPEUTICS
  • 7.3. DIAGNOSTICS

8. HUMAN MICROBIOME MARKET, BY DISEASE

  • 8.1. INTRODUCTION
  • 8.2. ACUTE DIARRHEA
  • 8.3. OBESITY
  • 8.4. DIABETES
  • 8.5. AUTOIMMUNE DISORDERS
  • 8.6. CANCER
  • 8.7. MENTAL DISORDERS
  • 8.8. OTHER DISEASES

9. HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY PRODUCT

  • 9.1. INTRODUCTION
  • 9.2. INSTRUMENTS
    • 9.2.1. LABORATORY INSTRUMENTS
    • 9.2.2. ANALYZERS
  • 9.3. CONSUMABLES
    • 9.3.1. KITS
    • 9.3.2. REAGENTS

10. HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY TECHNOLOGY

  • 10.1. INTRODUCTION
  • 10.2. CELL CULTURE TECHNOLOGY
  • 10.3. HIGH-THROUGHPUT TECHNOLOGY
  • 10.4. OMICS TECHNOLOGY
  • 10.5. COMPUTATIONAL TOOLS

11. HUMAN MICROBIOME MARKET, BY REGION

  • 11.1. INTRODUCTION
  • 11.2. NORTH AMERICA
    • 11.2.1. U.S.
    • 11.2.2. CANADA
  • 11.3. EUROPE
  • 11.4. ASIA-PACIFIC
  • 11.5. REST OF THE WORLD (ROW)

12. COMPETITIVE LANDSCAPE

  • 12.1. OVERVIEW
  • 12.2. COMPETITIVE SITUATION AND TRENDS
    • 12.2.1. AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
    • 12.2.2. EXPANSIONS
    • 12.2.3. PRODUCT LAUNCHES AND APPROVALS
    • 12.2.4. OTHER DEVELOPMENTS

13. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 13.1. ENTEROME BIOSCIENCE
  • 13.2. E.I. DU PONT DE NEMOURS AND COMPANY
  • 13.3. MERCK & CO., INC.
  • 13.4. METABIOMICS CORPORATION
  • 13.5. YAKULT HONSHA CO., LTD.
  • 13.6. MICROBIOME THERAPEUTICS, LLC
  • 13.7. OSEL, INC.
  • 13.8. SECOND GENOME, INC.
  • 13.9. VITHERA PHARMACEUTICALS
  • 13.10. VEDANTA BIOSCIENCES, INC.

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

14. APPENDIX

  • 14.1. INSIGHTS FROM INDUSTRY EXPERTS
  • 14.2. DISCUSSION GUIDE
  • 14.3. OTHER DEVELOPMENTS
  • 14.4. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.5. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 14.6. AVAILABLE CUSTOMIZATIONS
  • 14.7. RELATED REPORTS
  • 14.8. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2022-2025 (USD MILLION)
  • TABLE 2: HUMAN MICROBIOME MARKET SIZE FOR PROBIOTICS, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 3: HUMAN MICROBIOME MARKET FOR FOODS, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 4: HUMAN MICROBIOME MARKET SIZE FOR PREBIOTICS, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 5: HUMAN MICROBIOME MARKET SIZE FOR MEDICAL FOODS, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 6: HUMAN MICROBIOME MARKET SIZE FOR DIAGNOSTIC DEVICES, BY REGION, 2020-2025 (USD MILLION)
  • TABLE 7: HUMAN MICROBIOME MARKET SIZE FOR DRUGS, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 8: HUMAN MICROBIOME MARKET SIZE FOR OTHER PROBIOTIC SUPPLEMENTS, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 9: HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2022-2025 (USD MILLION)
  • TABLE 10: HUMAN MICROBIOME MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 11: HUMAN MICROBIOME MARKET SIZE FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2021-2025 (USD MILLION)
  • TABLE 12: HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2022-2025 (USD MILLION)
  • TABLE 13: HUMAN MICROBIOME MARKET SIZE FOR ACUTE DIARRHEA, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 14: HUMAN MICROBIOME MARKET SIZE FOR OBESITY, BY REGION, 2021-2025 (USD MILLION)
  • TABLE 15: HUMAN MICROBIOME MARKET SIZE FOR DIABETES, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 16: HUMAN MICROBIOME MARKET SIZE FOR AUTOIMMUNE DISORDERS, BY REGION, 2021-2025 (USD MILLION)
  • TABLE 17: HUMAN MICROBIOME MARKET SIZE FOR CANCER, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 18: HUMAN MICROBIOME MARKET SIZE FOR MENTAL DISORDERS, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 19: HUMAN MICROBIOME MARKET SIZE FOR OTHER DISEASES, BY REGION, 2021-2025 (USD MILLION)
  • TABLE 20: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 21: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 22: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR INSTRUMENTS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 23: NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR INSTRUMENTS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 24: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR LABORATORY INSTRUMENTS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 25: NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR LABORATORY INSTRUMENTS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 26: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR ANALYZERS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 27: NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR ANALYZERS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 28: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CONSUMABLES, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 29: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CONSUMABLES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 30: NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CONSUMABLES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 31: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR KITS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 32: NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR KITS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 33: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR REAGENTS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 34: NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR REAGENTS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 35: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 36: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CELL CULTURE TECHNOLOGY, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 37: NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CELL CULTURE TECHNOLOGY, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 38: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR HIGH-THROUGHPUT TECHNOLOGY, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 39: NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR HIGH-THROUGHPUT TECHNOLOGY, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 40: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR OMICS TECHNOLOGY, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 41: NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR OMICS TECHNOLOGY, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 42: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR COMPUTATIONAL TOOLS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 43: NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR COMPUTATIONAL TOOLS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 44: HUMAN MICROBIOME MARKET SIZE, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 45: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 46: NORTH AMERICA: HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2022-2025 (USD MILLION)
  • TABLE 47: NORTH AMERICA: HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2022-2025 (USD MILLION)
  • TABLE 48: NORTH AMERICA: HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2022-2025 (USD MILLION)
  • TABLE 49: NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 50: NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 51: NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CONSUMABLES, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 52: NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 53: U.S.: HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2022-2025 (USD MILLION)
  • TABLE 54: U.S.: HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2022-2025 (USD MILLION)
  • TABLE 55: U.S.: HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2022-2025 (USD MILLION)
  • TABLE 56: U.S.: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 57: U.S.: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 58: U.S.: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CONSUMABLES, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 59: U.S.: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 60: CANADA: HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2022-2025 (USD MILLION)
  • TABLE 61: CANADA : HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2022-2025 (USD MILLION)
  • TABLE 62: CANADA : HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2022-2025 (USD MILLION)
  • TABLE 63: CANADA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 64: CANADA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 65: CANADA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CONSUMABLES, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 66: CANADA: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 67: EUROPE: HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2022-2025 (USD MILLION)
  • TABLE 68: EUROPE: HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2022-2025 (USD MILLION)
  • TABLE 69: EUROPE: HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2022-2025 (USD MILLION)
  • TABLE 70: EUROPE: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 71: EUROPE: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 72: EUROPE: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CONSUMABLES, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 73: EUROPE: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 74: ASIA-PACIFIC: HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2022-2025 (USD MILLION)
  • TABLE 75: ASIA-PACIFIC: HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2020-2025 (USD MILLION)
  • TABLE 76: ASIA-PACIFIC: HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2022-2025 (USD MILLION)
  • TABLE 77: APAC: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION
  • TABLE 78: APAC: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 79: APAC: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CONSUMABLES, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 80: APAC: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 81: ROW: HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2022-2025 (USD MILLION)
  • TABLE 82: ROW: HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2022-2025 (USD MILLION)
  • TABLE 83: ROW: HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2022-2025 (USD MILLION)
  • TABLE 84: ROW: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 85: ROW: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 86: ROW: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE FOR CONSUMABLES, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 87: ROW: HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 88: AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2013-2016
  • TABLE 89: EXPANSIONS, 2013-2016
  • TABLE 90: PRODUCT LAUNCHES AND APPROVALS, 2013-2016
  • TABLE 91: OTHER DEVELOPMENTS, 2013-2016

LIST OF FIGURES

  • FIGURE 1: HUMAN MICROBIOME: MARKET SEGMENTATION
  • FIGURE 2: HUMAN MICROBIOME RESEARCH SPENDING: MARKET SEGMENTATION
  • FIGURE 3: RESEARCH DESIGN
  • FIGURE 4: MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 5: MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • FIGURE 6: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 7: PROBIOTICS SEGMENT TO DOMINATE THE HUMAN MICROBIOME MARKET DURING THE FORECAST PERIOD
  • FIGURE 8: CONSUMABLES SEGMENT TO WITNESS THE HIGHEST GROWTH RATE IN THE MICROBIOME RESEARCH SPENDING MARKET FROM 2016 TO 2021
  • FIGURE 9: CELL CULTURE TECHNOLOGIES TO DOMINATE THE HUMAN MICROBIOME RESEARCH SPENDING MARKET IN 2015
  • FIGURE 10: GEOGRAPHICAL SNAPSHOT OF THE GLOBAL HUMAN MICROBIOME MARKET, 2022
  • FIGURE 11: GROWING PREVALENCE OF LIFESTYLE DISEASES AND INCREASING ACCEPTANCE OF MICROBIOME-BASED PRODUCTS ARE MAJOR GROWTH DRIVERS
  • FIGURE 12: PROBIOTICS SEGMENT DOMINATED THE HUMAN MICROBIOME MARKET IN 2022
  • FIGURE 13: NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE HUMAN MICROBIOME MARKET IN 2022-2025
  • FIGURE 14: NORTH AMERICA TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 15: DEVELOPED REGIONS TO GROW AT HIGHER CAGRS FROM 2022 TO 2025
  • FIGURE 16: CELL CULTURE TECHNOLOGY SEGMENT DOMINATED THE HUMAN MICROBIOME RESEARCH SPENDING MARKET IN 2015
  • FIGURE 17: HUMAN MICROBIOME MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 18: FUNDS PROVIDED FOR MICROBIOME RESEARCH BY VARIOUS MEDICAL RESEARCH AGENCIES
  • FIGURE 19: PROBIOTICS SEGMENT TO COMMAND THE LARGEST SHARE OF THE HUMAN MICROBIOME PRODUCT MARKET BY 2025
  • FIGURE 20: THE THERAPEUTICS SEGMENT TO COMMAND THE LARGEST SHARE OF THE HUMAN MICROBIOME APPLICATIONS MARKET BY 2025
  • FIGURE 21: ACUTE DIARRHEA EXPECTED TO BE THE LARGEST DISEASE SEGMENT OF THE HUMAN MICROBIOME MARKET IN 2022
  • FIGURE 22: GEOGRAPHIC SNAPSHOT (2022): NORTH AMERICA WILL BE THE FASTEST-GROWING REGION BY 2022
  • FIGURE 23: NORTH AMERICA TO GROW AT THE FASTEST RATE IN THE HUMAN MICROBIOME PRODUCT MARKET FROM 2022 TO 2025
  • FIGURE 24: EUROPE: HUMAN MICROBIOME MARKET SNAPSHOT
  • FIGURE 25: COMPANIES ADOPTED AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS AS THE KEY GROWTH STRATEGY OVER THE LAST THREE YEARS
  • FIGURE 26: BATTLE FOR MARKET SHARE: AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS ARE KEY GROWTH STRATEGIES FOR MARKET PLAYERS
  • FIGURE 27: GEOGRAPHIC REVENUE MIX OF TOP 3 MARKET PLAYERS
  • FIGURE 28: E.I. DU PONT DE NEMOURS AND COMPANY: COMPANY SNAPSHOT (2015)
  • FIGURE 29: MERCK & CO., INC.: COMPANY SNAPSHOT (2015)
  • FIGURE 30: YAKULT HONSHA CO., LTD.: COMPANY SNAPSHOT (2016)
Back to Top